Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

82773-21-5Bromocriptine EP Impurity F

● In Stock

Catalogue No.:	VE0013138
CAS No.:	82773-21-5
Mol. Formula:	C32H40BrN5O5
Mol. Weight:	654.61 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 82773-21-5

Parent drug

Bromocriptine

IUPAC Name

(6aR, 9R)-5-bromo-N-[(2S, 5S, 10aS, 10bS)-10b-hydroxy-2- (1-methylethyl)-5-(2-methylpropyl)-3, 6-dioxooctahydro- 8H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl]-7-methyl- 4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinoline-9- carboxamide

Synonyms

(2’S)-2-Bromo-α-ergocriptine

Smiles

O=C([C@H](C=C12)CN(C)[C@]2([H])CC3=C(Br)NC4=C3C1=CC=C4)N[C@](O5)(C(C)C)C(N6[C@]5(O)[C@@](CCC7)([H])N7C([C@@H]6CC(C)C)=O)=O

InChI

InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31+,32+/m1/s1

Description

Bromocriptine EP Impurity F also known in pharmacopoeias as (2′S)-2-bromo-α-ergocryptine is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Bromocriptine. Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses.